The proteomic profiling of 232 ccRCC samples obtained from Fudan University Shanghai Cancer Center (FUSCC) was analyzed to validate the protein expression of PRMT5 in ccRCC. The gene discussed is PRMT5; the disease is nonpapillary renal cell carcinoma.